Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

Lynne Braidwood

Business Development Manager

Medicines Discovery Catapult

Macclesfield, United Kingdom

Lynne collaborates with pharmaceutical companies, biotech firms, SMEs, and academic researchers, helping them develop and execute studies by leveraging MDC’s expertise, technology, and wet labs

My organisation

Medicines Discovery Catapult

Medicines Discovery Catapult

Research Institution/University

Macclesfield, United Kingdom

Medicines Discovery Catapult (MDC) accelerates drug discovery through collaborative R&D, providing a specialized platform to transition Radiopharmaceutical Therapy (RPT) from concept to clinical readiness. MDC's RPT focus includes radiochemistry, dosimetry, advanced translational imaging, and validation via patient-derived tumor models (PDX). For more details, visit Medicines Discovery Catapult.
Read more

Marketplace (1)

  • Partnership

    Radiopharmaceutical preclinical studies

    If you are interested in running pre clinical studies using your targeted company, we can radiolabel it with Lu177, Ac225 or other isotopes and run the Biodistribution, effacacy and diameter studies required to move your asset along the pipeline

    Author

    Lynne Braidwood

    Business Development Manager at Medicines Discovery Catapult

    Macclesfield, United Kingdom